Skip to content
healthcare.dev
Get a free key

Rivaroxaban

NDC 50228-513, Rivaroxaban, tablet, film coated, from ScieGen pharmaceuticals,Inc.

Product NDC
50228-513
Status
Listed
Labeler
ScieGen pharmaceuticals,Inc
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA218117
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50228-513 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RIVAROXABAN2.5 mg/1

Pharmacologic classes

Factor Xa Inhibitor [EPC]; Factor Xa Inhibitors [MoA]

Package NDCNDC-11Package
50228-513-1850228051318180 TABLET, FILM COATED in 1 BOTTLE (50228-513-18)
50228-513-605022805136060 TABLET, FILM COATED in 1 BOTTLE (50228-513-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/3b53cebf-946c-b82b-e063-6394a90a5da7

  • NADAC price for package 50228051318

    GET /v1/drugs/nadac/50228051318

  • NADAC price for package 50228051360

    GET /v1/drugs/nadac/50228051360

Use it

Look up 50228-513 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50228-513 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50228-513. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.